ERIS Lifesciences Ltd.
BSE: 540596 | Sector: Health care |
NSE: ERIS | ISIN Code: INE406M01024 |
BSE 00:00 | 25 Feb | 590.10 |
-7.15 (-1.20%) |
OPEN
608.90 |
HIGH
608.90 |
LOW
586.05 |
NSE 00:00 | 25 Feb | 591.70 |
-7.20 (-1.20%) |
OPEN
600.00 |
HIGH
605.00 |
LOW
585.00 |
OPEN | 608.90 |
PREVIOUS CLOSE | 597.25 |
VOLUME | 1067 |
52-Week high | 642.50 |
52-Week low | 341.05 |
P/E | 23.82 |
Mkt Cap.(Rs cr) | 8,014 |
Buy Price | 590.10 |
Buy Qty | 200.00 |
Sell Price | 599.20 |
Sell Qty | 6.00 |
About ERIS Lifesciences Ltd.
Eris Lifesciences Limited was incorporated on January 25 2007. Subsequently the name of the company was changed to 'Eris Lifesciences Private Limited' on February 9 2007. Further the company was converted into a public limited company and the name was changed to 'Eris Lifesciences Limited' on February 2 2017. The company develops manufactures and commercializes branded pharmaceutical products in s...> More
ERIS Lifesciences Ltd - Key Fundamentals
Parameter | Values | ||
Market Cap | (![]() |
8,014 | |
EPS - TTM | (![]() |
[*S] | 24.77 |
P/E Ratio | (X) | [*S] | 23.82 |
Face Value | (![]() |
1 | |
Latest Dividend | (%) | 550.00 | |
Latest Dividend Date | 13 Aug 2020 | ||
Dividend Yield | (%) | 0.49 | |
Book Value / Share | (![]() |
[*S] | 104.38 |
P/B Ratio | (![]() |
[*S] | 5.65 |
News
Announcement
-
Eris Lifesciences Limited - Analysts/Institutional Investor Meet/Con. Call Updates
-
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
-
Eris Lifesciences Limited - Analysts/Institutional Investor Meet/Con. Call Updates
-
Intimation Of Receipt Of Request For Re-Classification From Promoter And Promoter Group To Public Ca
-
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
ERIS Lifesciences Ltd - Financial Results
Particulars (![]() |
Dec 2020 | Dec 2019 | % Chg |
Net Sales | 310.42 | 266.4 | 16.52 |
Other Income | 3.07 | 8.47 | -63.75 |
Total Income | 313.5 | 274.87 | 14.05 |
Total Expenses | 203.19 | 189.62 | 7.16 |
Operating Profit | 110.3 | 85.25 | 29.38 |
Net Profit | 90.15 | 63.47 | 42.04 |
Equity Capital | 13.58 | 13.75 | - |
ERIS Lifesciences Ltd - Peer Group
Company | Price(![]() |
Chg (%) | Mkt Cap (![]() |
J B Chem & Pharm | 1138.95 | 1.15 | 8804.08 |
Astrazeneca Phar | 3508.55 | 0.44 | 8771.38 |
Granules India | 326.65 | 0.26 | 8091.12 |
ERIS Lifescience | 590.10 | -1.20 | 8013.56 |
Strides Pharma | 854.05 | 2.15 | 7656.56 |
Sequent Scien. | 245.90 | 4.42 | 6106.93 |
Aarti Drugs | 635.60 | 0.03 | 5923.79 |
ERIS Lifesciences Ltd - SHAREHOLDING PATTERN
|
|
ERIS Lifesciences Ltd - RETURNS
Period | BSE | NSE | Sensex | NIFTY |
1 Week | 2.16% | 2.38% | -0.56% | -0.73% |
1 Month | -3.44% | -3.54% | 5.57% | 5.05% |
3 Month | 12.97% | 13.49% | 16.45% | 15.64% |
6 Month | 9.72% | 7.90% | 31.40% | 31.67% |
1 Year | 39.90% | 39.80% | 26.71% | 27.63% |
3 Year | -19.58% | -19.66% | 49.49% | 43.91% |
ERIS Lifesciences Ltd - STOCK STRENGTH
Today's Low/High | 586.05 | 608.90 | |
Week Low/High | 552.85 | 608.90 | |
Month Low/High | 552.85 | 639.00 | |
YEAR Low/High | 341.05 | 643.00 | |
All TIME Low/High | 341.05 | 896.00 |
Quick Links for ERIS Lifesciences:
-
News
Announcements Brokerage Reports Business Earnings Sector -
Corporate Action
AGM Board Meetings Bonus Dividends EGM Rights Split -
INFORMATION
Bulk Deals Company History MF Holding Listing Info Locations Shareholding -
Financials
Financial Overview Balance Sheet Profit & Loss Cash Flow Ratios Quarterly Results Half Yearly Results Nine Monthly Results Yearly Results -
Annual Report
Auditors Report Chairman's Speech Company Management Directors' Report Finished Goods Raw Materials -
Peer Comparison
Competition Market Cap Price Price Performance Net Sales Net Profit Total Assets Historical Prices